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JoPurpose of review: In-vivo measurement of retinal
vascular calibers may be used as a tool to study the
pathophysiology and clinical status of the microvasculature
of the retina. The aim of this study was to generate
normative data for retinal vessel parameters, and to
evaluate the clinical relevance in systemic hypertension.
Methods: Fundus photographs from 4309 participants of
the Gutenberg Health Study were assessed using the
‘retinal vessel analyzer’ software (IMEDOS). We generated
age and sex-specific nomograms in a disease-free
subpopulation of 890 participants for determining the
central retinal arteriolar equivalent (CRAE), the central
retinal venular equivalent, and the arteriovenous ratio
(AVR).
Results: Women had higher values of CRAE, central
retinal venular equivalent, and AVR than men, and the
decrease in measures with increasing age was less steep in
women than in men. Systemic hypertension was associated
with lower values [odds ratio (OR), 95% confidence
interval (CI) referring to area below the 5% percentile] of
AVR (men: OR 2.41, 95% CI 1.669–3.490, P< 0.001;
women: OR 3.01, 95% CI 2.126–4.268, P<0.001) and
CRAE (men: OR 2.60, 95% CI 1.563–4.326, P<0.001,
women: OR 3.00, 95% CI 2.004–4.487, P<0.001). Both
median CRAE and AVR were lower in participants with
uncontrolled hypertension (172.28, range 83.05–251.04;
and 0.81, range 0.56–1.04) versus those with screening-
detected hypertension (175.72, range 101.23–222.09,
P<0.001; and 0.82, range 0.64–1.05, P¼0.001), and
versus those with controlled (179.10, range 108.19–
221.92, P<0.001; and 0.84, range 0.60–1.08, P<0.001)
hypertension.
Conclusion: The study provides sex and age-specific
normative data for retinal vasculature. Persons with
untreated or insufficiently treated hypertension are more
likely to have retinal vessel equivalents outside the
reference range.
Keywords: arteriovenous ratio, epidemiology,
hypertension, retinal vessel metrics, stroke
Abbreviations: AVR, arteriovenous ratio; CRAE, central
retinal arteriolar equivalent; CRVE, centra retinal venular Copyright © 2017 Wolters Kluwer
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he retinal vasculature provides a unique window to
assess human vessels noninvasively and directly
in vivo [1,2]. Retinal vascular caliber changes reflect
cumulative responses to aging, cardiovascular risk factors,
inflammation, endothelial dysfunction, and other processes
[3,4]. Identification of early microvascular changes using
reliable and reproducible imaging techniques may there-
fore be used as a screening modality for the assessment of
cardiovascular disease, and especially for the management
of both the ocular and systemic complications of hyper-
tension [5]. In a cross-sectional study, the Prospective
Cardiovascular Mu¨nster Study (PROCAM) and Systematic
Coronary Risk Evaluation (SCORE) risk estimates were
associated with retinal vessel equivalents [6]. Recently, it
has been shown that retinal vessel parameters are associ-
ated with long-term mortality in the general adult Dutch
population [7]. Retinal vascular calibers are associated with
a wide range of subclinical (e.g. atherosclerosis, inflam-
mation, and endothelial dysfunction) and clinical cardio-
vascular diseases (hypertension, coronary heart disease, Health, Inc. All rights reserved.
DOI:10.1097/HJH.0000000000001380
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[1,8–12], and also with high blood pressure during preg-
nancy and preeclampsia [13,14]. The association of retinal
vessel parameters with cardiovascular and cerebrovascular
disease has also been studied in several epidemiological
studies [4,9,15–20]. Recently, a large systematic meta-
analysis [21] examined the association between retinal
vascular caliber and incident hypertension, and found that
retinal arteriolar narrowing and venular widening were
independently associated with an increased risk of hyper-
tension. Amethod of semiautomatic measurement of retinal
vascular calibers may thus be used as a noninvasive clinical
and research tool to further study the role and pathophysi-
ology of the microvasculature and as a cardiovascular risk
prediction tool. Additionally, in the present literature,
retinal diameters were evaluated as relative values only,
as no normative data have been published so far. Normative
data could also be used to perform meta-analyses within
joint projects of the European Eye Epidemiology (E3)
Consortium, for example [22,23]. We therefore aimed to
generate reference data for retinal vessel metrics and to
analyze the association between these parameters and
cardiovascular risk factors and diseases in a large German
population-based cohort. We focused on the clinical
relevance of these parameters in systemic hypertension
to evaluate whether ‘abnormal’ retinal vessel calibers might
be helpful for risk stratification of hypertensive patients.
METHODS
The Gutenberg Health Study
The Gutenberg Health Study (GHS) is a population-based,
prospective, observational single-center cohort study in
Midwestern Germany, with a total of 15 010 participants
between age 35 and 74 at recruitment. The sample was
randomly drawn from local governmental registry offices,
and equally stratified by sex and residence (urban and
rural) per decade of age. The sample was drawn in similar
waves to allow subsample analyses after the inclusion of
5000 participants. Participants underwent a standardized
protocol including an ophthalmic and a complete general
medical examination focused on cardiovascular
parameters. The detailed protocol has been described
previously [24]. Fundus images were recorded with a non-
mydriatic fundus camera (Visucam PRO NMTM; Carl Zeiss
AG, Jena, Germany) in a darkened room and with the
pupil’s natural width. Three photographs were taken of
each eye: at 308 and 458 centered on the optic nerve, and at
308 centered on the macula. For retinal vessel analysis, we
used the 458 optic nerve centered photos of a representative
subsample with the first 5000 GHS participants.
The methodology of how hypertension was diagnosed
and blood pressure was measured in the GHS has been
published previously [25], and the methodology has been
compared to other studies [26]. We used the OMRON HEM-
705CP II to measure blood pressure on the right arm in an
upright sitting position on a height-adjustable chair with the
back supported, legs uncrossed and feet on the ground, and
with the lower arm resting on the table at heart level. The
breadth of the cuff was chosen according to the width of the
arm in every participant. The resting time before the first Copyright © 2017 Wolters Kluwe
1636 www.jhypertension.commeasurement was 3min. Unfortunately, we were not able
to perform any out-of-office blood pressure measurements
in order to avoid white coat hypertension. Arterial hyper-
tensionwas diagnosed if antihypertensive drugs were taken
or if the mean systolic blood pressure was at least
140mmHg or if the mean diastolic blood pressure was at
least 90mmHg in the second and third standardized
measurements after 8 and 11min of rest, respectively. To
further assess patients with arterial hypertension, therapy
status was documented. In the present study, we compared
persons with different stages of hypertension according to
the following definition:r H1.eaNo hypertension: Blood pressure systolic below
140mmHg and diastolic below 90mmHg, and no
antihypertensive medication.2. Controlled hypertension: Blood pressure systolic
below 140mmHg and below 90mmHg, and intake
of antihypertensive medication.3. Screening detected (in GHS examination) hyper-
tension: Blood pressure systolic at least 140mmHg
and/or diastolic at least 90mmHg that is unknown by
the participant.4. Uncontrolled hypertension: Blood pressure systolic
at least 140mmHg and/or diastolic at least 90mmHg,
intake of antihypertensive medication or blood pres-
sure systolic at least 140mmHg and/or diastolic at
least 90mmHg, and no intake of antihypertensive
medication, although diagnosed by a physician.Other cardiovascular risk factors and diseases were
measured as previously reported [27,28]: Smoking was
dichotomized into nonsmokers (never smokers and ex-
smokers) and smokers (occasional smokers and smokers).
Diabetes was diagnosed in individuals with a definite
diagnosis and treatment of diabetes by a physician, a blood
glucose level at least 126mg/dl at the baseline examination
after overnight fasting of at least 8 h or a blood glucose level
of at least 200mg/dl at the baseline examination after a
fasting period of less than 8h. As previously published [29],
prediabetes was defined according to HbA1c (38.8–
46.45mmol/mol or 5.8–6.4%). Dyslipidemia was defined
as a definite diagnosis of dyslipidemia by a physician or a
low-density lipoprotein (LDL)/high-density lipoprotein
(HDL) ratio of at least 3.5. Obesity was defined as a BMI
at least 30 kg/m2. Taking the participants’ histories from
computer-assisted personal interviews, we also investi-
gated whether sex, age, presence of peripheral arterial
occlusive disease, chronic heart failure, coronary heart dis-
ease, and family history for previous stroke or myocardial
infarction were associated with retinal vessel calibers. To be
able to calculate normative data, we defined persons as
‘cardiovascular healthy’ if the following cardiovascular risk
factors or conditions were absent: systemic hypertension,
diabetes, smoking, dyslipidemia, obesity, peripheral arterial
occlusive disease, (medicated) heart failure, history or family
history for stroke or myocardial infarction. All participants
with one or more of these conditions were considered as
having cardiovascular disease or ‘ill.’
The study protocol and study documents were approved
by the local ethics committee of the Medical Chamber oflth, Inc. All rights reserved.
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original vote: 22 March 2007; latest update: 20 October
2015). Written informed consent was obtained from
patients after explanation of the nature and possible con-
sequences of the study. This research adhered to the tenets
of the Declaration of Helsinki.
Retinal vessel analysis
Static retinal vessel analysis was performed by two trained
graders (D.J.W., L.W.) using VesselMap II Software (Imedos
Systems, Jena, Germany, Version 3.02. 2006). Principles
of static vessel analysis have been described in previous
study [30]. Briefly, the optic nerve disc is marked in a disk-
centered image. The software then creates an area of one
half to one disk diameter distance around the optic disk to
measure all vessels. A cross divides the area into four
quadrants. In these quadrants, arterioles and venules are
differentiated and selected manually. The central retinal
arteriolar equivalent (CRAE), the central retinal venular
equivalent (CRVE), and the arteriovenous ratio (AVR) were
calculated using the formula by Parr and Spears [31] and
Hubbard et al. [30]. We used AVR as it is dimensionless and
therefore independent from refraction and magnification
effects, but we also used CRAE and CRVE to separately
capture information of the individual arteriolar and venular
caliber components. To assess interobserver reliability, all
quantitative parameters (CRAE, CRVE, and AVR), and also
image quality were assessed by both graders in 136 images,
and interclass correlation coefficients and kappa statistics
were computed. A random number generator was used to
randomly select the photographs of the right and left eyes,
respectively. If a selected photo was not available or if
image quality was insufficient, the contralateral eye was
chosen for retinal vessel analyses.
Statistical analyses
We performed statistical analyses using SPSS (Statistical
Package for the Social Sciences, Version 23, Chicago,
Illinois, USA), SAS (Statistical Analysis System) software,
Version 9.4 of the SAS System for Windows (Copyright 
2002–2012 SAS Institute Inc., Cary, North Carolina, USA)
and R version 3.2.3 software [32].
Age and sex-specific nomograms and reference ranges
for AVR were calculated with quantile regression analysis.
For univariate analyses (associations of CRAE, CRVE, and
AVRwith cardiovascular risk factors and disease), a t test for
binary variables and a Kruskal–Wallis test for nominal
variables were used. With a multivariable logistic regression
model [odds ratio (OR), confidence interval (CI), and P
value], we determined whether values of CRAE, CRVE, and
AVR below the 5% percentile were associated with cardi-
ovascular disease and risk factors. We simultaneously
adjusted for the diameter of the other vascular system, as
it has been shown that retinal arteriolar and venular caliber
sizes are highly correlated. Individuals with narrower arte-
rioles are more likely to have narrower venules [33]. A
Cochrane Armitage test for trend was used to assess the
association between therapy status of hypertension (con-
trolled versus uncontrolled versus screening-detected hy-
pertension) with the proportion of persons with values
below the reference ranges of CRAE and AVR. As it has Copyright © 2017 Wolters Kluwer
Journal of Hypertensionbeen shown previously that narrowing of the retinal arterio-
lar vasculature is an important sign of systemic hyper-
tension and that a lower AVR seems to predict the risk of
hypertension [34], we focused on CRAE and AVR in
these individuals.
Because of the explorative character of the analysis, we
did not define a significant threshold for P values. The P
values should be interpreted as a continuous measure of
statistical evidence.
RESULTS
Descriptive data
Fundus photographs of sufficient quality were available
from 4309 participants with 2164 and 2145 randomly
selected right and left eyes, respectively.
The mean AVRs of the right and left eyes were
0.840 0.067 and 0.845 0.071, respectively (P¼ 0.013),
whereas CRAE and CRVE were 177.42 17.50 versus
179.33 18.27 (P< 0.001), and 211.80 17.50 versus
212.79 17.40 (P¼ 0.063) in right versus left eyes, respec-
tively. Except for the variable ‘family history for myocardial
infarction’ (18.4% in participants with selected right eyes
versus 16.3% in participants with selected left eyes), no
differences were found between the randomly selected right
and left eyes and the other variables used for adjustment
(age, sex, and cardiovascular risk factors and diseases).
In all eyes, the means for AVR, CRAE, and CRVE were
0.84 0.07, 178.37 17.91, and 212.30 17.45, respec-
tively.
Of the 4309 participants, 2162 (50.2%) were men and
2147 (49.8%) were women. At inclusion into the study, the
mean age was 54.8 10.8 years, with 2242 (52.0%) partici-
pants aged 55 years and younger, and 2067 (48.0%) aged
older than 55 years. Arterial hypertension, diabetes, pre-
diabetes, obesity, dyslipidemia, peripheral artery occlusive
disease, and (medicated) heart failure were present in 2150
(49.9%), 283 (6.6%), 420 (9.7%), 1013 (23.5%), 1270
(29.5%), 167 (3.8%), and 62 (1.4%) participants, respec-
tively. In this study, 851 (19.7%) participants were smokers.
We noted a history or a family history of stroke in 77 (1.8%)
and 370 (8.6%) participants, respectively, and of myocardial
infarction in 114 (2.6%), and 756 (17.5%) participants,
respectively.
Retinal vessel diameters in cardiovascular
‘healthy’ versus ‘ill’ participants
According to the above-mentioned definition, participants
were categorized into ‘cardiovascular ill’ (n¼ 3405; 79.0%)
or ‘cardiovascular healthy’ (n¼ 890; 20.6%) subgroups (in
n¼ 14, data on cardiovascular risk factors were missing).
The mean CRAE was lower in the ‘ill’ (177.32 17.84)
than in the ‘healthy’ group (182.42 17.56) (P< 0.001). The
mean CRVE was 212.55 17.55 in the ‘ill’ versus
211.24 17.08 in the healthy group (P¼ 0.046). The mean
AVR was 0.84 0.07 in ‘ill’ and 0.87 0.06 in ‘healthy’
participants (P< 0.001).
Interobserver variability
Regarding interobserver variability, we found a kappa of
0.643 between investigators’ evaluations of image quality Health, Inc. All rights reserved.
www.jhypertension.com 1637
FIGURE 1 Analysis of interobserver variability. The Bland–Altman plot illustrates
the interobserver variability: in 136 fundus photos, the arteriovenous ratio (AVR)
was determined by the two observers. The mean difference between these
observers was 0.0042 with a standard deviation of 0.02861. The interclass
coefficient for these differences was 0.896 (P<0.001).
Ponto et al.and an interclass correlation coefficient of 0.896 (P< 0.001)
for AVR measurements (mean difference 0.004, 95% CI
0.001 to 0.009, P¼ 0.090). Figure 1 illustrates the
Bland–Altman plot for the differences of the measured
values of AVR between the two observers. The interclass
correlation coefficients for CRAE and CRVE were 0.94
(0.91–0.95) and 0.96 (0.94–0.97), respectively.
Normative data
Age and sex-specific reference values and nomograms
were calculated on the basis of values for AVR, CRAE,
and CRVE for 890 cardiovascular healthy individuals. A
quantile regression analysis was performed to calculate
linear equations for the 1st, 5th, and 10th percentiles for
these participants. Figure 2 (a–c) illustrates the age and-
sex-specific nomograms for AVR, CRAE, and CRVE, respec-
tively.
Furthermore, we calculated the reference ranges (from
the 2.5th to 97.5th percentiles) for men and women aged 55
years and younger, and aged over 55 years, for AVR, CRAE,
and CRVE (Table 1).
General and cardiovascular association of
retinal vessel diameters
Table 2 summarizes the (univariate) associations between
AVR, CRAE, and CRVE and age, sex, and cardiovascular
risk factors.
On the basis of the quantile regression analysis, a logistic
regression was performed with ORs referring to the area
under the fifth percentile. The linear equations pertaining to
the fifth percentile are illustrated in Table 3. The results of
the multivariate analysis are summarized in Tables 4–6.
Clinical relevance of retinal vessel analysis
Regarding systemic hypertension and the status of antihy-
pertensive therapy, we compared retinal vessel diameters
between the following groups: participants with controlled
versus screening-detected (participants who had been Copyright © 2017 Wolters Kluwe
1638 www.jhypertension.comunaware of their hypertension when they participated in
the GHS) versus uncontrolled systemic hypertension.
Figure 3 (a and b) illustrates the differences between the
values of AVR and CRAE in these groups.
On the basis of these findings and the knowledge about
the reference ranges of the retinal vessel diameters, we
assessed the proportion of persons in the subgroups (con-
trolled versus screening-detected versus uncontrolled
hypertension) with values below the reference range of
AVR and CRAE. With only one exception (men older than
55), the proportion of patients with values for AVR and
CRAE below the reference range was higher in those with
controlled hypertension than in those with screening-
detected or uncontrolled hypertension (Table 7).
DISCUSSION
The GHS is the first population-based study to publish age
and sex-specific normative data for retinal vessel metrics
and assessed retinal vessels in the youngest European
population-based cohort of adults. The following novel
findings were made: narrowing of the retinal arteriolar
vasculature is associated not only with hypertension but
also with the status of antihypertensive therapy: persons
with untreated or insufficiently treated hypertension are
more likely to have vessel calibers outside the reference
range.
Currently, no age and sex-specific reference cut-off
values for retinal vascular calibers have been established,
probably because it is important to account for a wide range
of potential confounders (e.g. systemic hypertension,
diabetes, retinopathy) for retinal vessel measurements.
To create normative data, retinal vascular calibers were
assessed in healthy children, who are presumably free of or
have had fewer systemic and environmental influences so
far, and may therefore provide better reference values [35].
Nevertheless, a value considered as normal for children
may not be normal for adults. In the GHS normative data,
we distinguished a ‘healthy’ subgroup of individuals who
were free frommajor cardiovascular risk factors and cardio-
vascular disease. When compared to the ‘cardiovascular
diseased’ subgroup, these persons had a lower CRAE and
AVR and a higher CRVE. In the nomograms, we found
differences between men and women: regarding the retinal
AVR, women had higher values thanmen across all decades
of age, and the decrease in AVRwith increasing agewas less
steep than in men. The same holds true for the nomograms
of CRAE and CRVE, where we additionally found that there
was a steeper decrease in the values with increasing age in
those with values lower than the 5% quantile than in those
with values above especially in men (but also in women).
The younger participants with lower values might have
disproportionally decreasing values with increasing age.
The association between increasing age and smaller vessel
diameters has been found in the Blue Mountains Eye Study
(BMES) [36], the Multiethnic Study of Atherosclerosis
(MESA) [4], the Beaver Dam Eye Study (BDES) [37], and
the Funagata Study [38]. Regarding the association with sex,
the BMES [36], the MESA [4], and the Cardiovascular Health
Study [39] found larger arteriolar calibers in women than
in men.r Health, Inc. All rights reserved.
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FIGURE 2 (a–c): Age and sex-specific nomograms. These nomograms were calculated on the basis of the values for the arteriovenous ratio (AVR), the central retinal
arteriolar equivalent (CRAE), and the central retinal venular equivalent (CRVE) of the ‘healthy’ subgroup (no cardiovascular risk factors; see ‘Methods’ section) of 890
persons. A quantile regression analysis was performed to calculate linear equations for the 1st, 5th, and 10th quartiles for these participants. The bold line in the middle
represents the fifth quantile, with 95% of the values being located in the areas above (90% in the top field) and 5% being located in the areas bolow it (1% in the floor
field). (a) Nomogram for AVR; (b) nomogram for CRAE; (c) nomogram for CRVE.
Retinal vessel analysis in the GHSIn the GHS, we also evaluated associations between the
retinal microvasculature and cardiovascular risk factors and
diseases. In a univariate analysis, lower CRAE and AVR
were associated with male sex, higher age, prediabetes, and
a history of hypertension. Moreover, AVR was lower in
individuals with obesity, dyslipidemia, and a history of
myocardial infarction, and it was higher in smokers. On Copyright © 2017 Wolters Kluwer
TABLE 1. Age and sex-specific reference ranges (2.5–97.5th percentil
retinal venular equivalent (CRVE), and the arteriovenous ra
Reference range (2.5th–97.5th percentile)
M
55 years
AVR 0.72–0.98
CRAE 143.07–213.74
CRVE 179.03–242.69
Journal of Hypertensionthe contrary, CRVE was higher in men, in persons with
obesity, dyslipidemia, or a family history for stroke, and in
smokers. These findings are quite consistent with those
from other epidemiological studies [1,3].
In a multivariable analysis, we adjusted for the fellow
vessel diameter as it has been shown that retinal arteriolar
and venular caliber sizes are highly correlated and that Health, Inc. All rights reserved.
es) of the central retinal arteriolar equivalent (CRAE), the central
tio (AVR) in the population-based Gutenberg Health Study (GHS)
en Women
>55 years 55 years >55 years
0.72–0.95 0.76–0.99 0.73–1.01
129.15–202.49 155.54–220.58 145.92–217.07
170.52–241.99 182.32–245.98 178.21–259.72
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TABLE 2. Associations between the central retinal arteriolar equivalent (CRAE), the central retinal venular equivalent (CRVE), and the
arteriovenous ratio (AVR) with age, sex, and cardiovascular risk factors in the population-based Gutenberg Health Study (GHS)
CRAE CRVE AVR
Mean standard
deviation P
Mean standard
deviation P
Mean standard
deviation P
Sex Men 176.1617.99 <0.001 211.6417.37 0.014 0.830.07 <0.001
Women 180.5917.55 212.9417.52 0.850.07
Age Age 55 years 181.2517.67 <0.001 212.7917.25 0.051 0.850.07 <0.001
Age >55 years 175.2517.65 211.7517.66 0.830.07
Arterial hypertension No 182.6017.53 <0.001 212.7717.37 0.064 0.860.07 <0.001
Yes 174.1118.00 211.7917.50 0.820.07
Diabetes No 178.3517.93 0.832 212.1517.38 0.059 0.840.07 0.097
Yes 178.5917.64 214.1818.50 0.840.07
Prediabetes No 178.6817.89 0.01 212.0317.30 0.230 0.850.07 <0.001
Yes 176.1017.58 213.1917.78 0.830.07
Obesity No 178.5618.19 0.181 211.5317.51 <0.001 0.850.07 <0.001
Yes 177.7416.96 214.7717.04 0.830.07
Dyslipidemia No 178.6018.01 0.220 211.7617.54 0.002 0.850.07 <0.001
Yes 177.8917.65 213.5617.23 0.840.07
Peripheral artery occlusive disease No 178.3917.87 0.471 212.2017.37 0.335 0.840.07 0.053
Yes 177.8718.53 213.5319.59 0.830.07
(Medicated) heart failure No 178.4117.92 0.324 212.3117.45 0.497 0.840.07 0.749
Yes 176.2317.17 210.7918.03 0.850.06
History of myocardial infarction No 178.4517.94 0.098 212.2317.43 0.254 0.840.07 0.002
Yes 175.6217.09 214.1318.55 0.820.07
Family history for myocardial infarction No 178.3518.10 0.899 212.1117.43 0.135 0.840.07 0.211
Yes 178.4416.97 213.1517.58 0.840.07
History of stroke No 178.4117.92 0.577 212.2917.43 0.944 0.840.07 0.483
Yes 177.2618.41 212.1418.46 0.840.07
Family history for stroke No 178.3317.88 0.642 212.1317.41 0.043 0.840.07 0.066
Yes 178.7818.20 214.0517.88 0.840.06
Smoking No 177.0417.60 <0.001 211.1017.17 <0.001 0.840.07 <0.001
Yes 183.8818.11 217.0917.86 0.850.07
Univariate analysis with P values according to t test.
Ponto et al.individuals with narrower arterioles are more likely to have
narrower venules [33].
The multivariate logistic regression analysis using indi-
viduals with values below the fifth percentile as a reference
supports the association of hypertension with lower values
of AVR and CRAE. The highest ORs were found in women,
in whom lower values of AVR were also associated with a
history of stroke. Smoking was associated with a larger
CRAE, CRVE, and AVR, especially in women. On the con-
trary, a larger CRVE was associated with the presence of a
peripheral arterial occlusive disease, especially in men. It
has been shown recently in another cohort that prediabetes Copyright © 2017 Wolters Kluwe
TABLE 3. Linear equations pertaining to the fifth percentile of
the values of the central retinal arteriolar equivalent
(CRAE), the central retinal venular equivalent (CRVE),
and the arteriovenous ratio (AVR) of the quantile
regression analysis
AVR All 0.0015 ageþ0.8361
Men 0.0017 ageþ0.8296
Women 0.0010 ageþ0.8190
CRAE All 0.5970 ageþ182.7074
Men 0.9018 ageþ192.4188
Women 0.3681 ageþ177.4745
CRVE All 0.2697 ageþ197.8669
Men 0.5436 ageþ208.1738
Women 0.2341 ageþ197.2955
1640 www.jhypertension.comwas independently associated with microvascular dysfunc-
tion [40]. Nevertheless, in the present study, only diabetes,
but not prediabetes, was associated with a higher CRAE
and AVR, respectively. Furthermore, it has been shown
that obesity was associated with reduced AVR in the retina
[41–43]. In the present study, obesity was associated with a
larger CRVE and a smaller AVR in the univariable analyses,
but no associations between obesity and the retinal vessel
equivalents were found in the multivariable analyses. In
contrast, the finding that arteriolar narrowing and a lower
arteriovenous ratio are associated with hypertension is in
line with other studies [1,2,5,12,15,44–46]. Moreover,
participants in the GHS with uncontrolled hypertension
had a smaller CRAE and AVR than those who were unaware
of their hypertension or those with sufficient antihyperten-
sive treatment. A higher proportion of insufficiently or
untreated patients had values below the reference ranges
than those with controlled hypertension. This finding adds
novel information to other clinically relevant findings
regarding retinal vessels in hypertension: It has been shown
that retinal vessel parameters are associated with the risk of
hypertension [21]: In the Atherosclerosis Risk in Commun-
ities study, normotensive participants with a lower AVR at
baseline were 60% more likely to be diagnosed with hy-
pertension [47]. Further data from the BDES [48], the BMES
[49], and the Rotterdam Study [34] showed that smaller
arteriolar calibers and AVR are preclinical markers of hyper-
tension. The reference ranges found in the GHS mightr Health, Inc. All rights reserved.
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TABLE 4. Association of the central retinal arteriolar equivalent (CRAE) with cardiovascular risk factors and diseases
CRAE (odds ratios refer to values
lower than the fifth quantile); All Men Women
adjusted for the fellow vessel diameter OR 95% CI P OR 95% CI P OR 95% CI P
Sex (reference¼men) 0.476 0.354–0.641 <0.001
Age 0.965 0.951–0.980 <0.001 0.945 0.921–0.970 <0.001 0.975 0.957–0.993 0.006
Hypertension 2.881 2.099–3.954 <0.001 2.600 1.563–4.326 <0.001 2.999 2.004–4.487 <0.001
Diabetes 0.405 0.169–0.976 0.044 0.646 0.189–2.212 0.487 0.303 0.087–1.052 0.060
Smoking 0.653 0.437–0.977 0.038 0.796 0.437–1.450 0.455 0.572 0.331–0.989 0.046
Dyslipidemia 1.189 0.864–1.638 0.288 1.069 0.660–1.732 0.785 1.181 0.765–1.824 0.452
Obesity 0.813 0.571–1.158 0.251 0.764 0.422–1.382 0.373 0.811 0.520–1.266 0.357
Family history of myocardial infarction 1.079 0.755–1.542 0.676 1.036 0.560–1.919 0.910 1.091 0.704–1.692 0.697
Family history of stroke 0.724 0.424–1.236 0.236 0.840 0.334–2.114 0.711 0.667 0.342–1.298 0.233
Peripheral arterial occlusive disease 0.542 0.217–1.350 0.188 0.829 0.318–2.161 0.702
(medicated) heart failure 1.222 0.368–4.054 0.743 1.580 0.200–12.500 0.665 1.043 0.240–4.530 0.955
Stroke 1.178 0.371–3.740 0.781 2.053 0.589–7.158 0.259
Myocardial infarction 0.403 0.090–1.798 0.234 1.059 0.217–5.179 0.944
Fellow vessel (central retinal venular
equivalent) lower than 5th quantile
21.585 15.262–30.528 <0.001 21.142 11.980–37.311 <0.001 20.921 13.425–32.604 <0.001
Logistic regression analysis with odds ratios (ORs), 95% confidence intervals (CIs), and P values referring to values lower than the fifth percentile.
CI, confidence interval; OR, odds ratio.
Retinal vessel analysis in the GHStherefore be useful as markers for optimizing/monitoring
hypertension therapy. If this can be confirmed by longi-
tudinal data, it may improve diagnostics and therapy con-
trol in hypertension, especially because it is known that
central blood pressure is more closely associated with
the narrowing of CRAE than brachial blood pressure [50].
In two population-based cohorts among children aged
6–8 years, each 10-mmHg increase in systolic blood
pressure was associated with narrowing of the retinal
arterioles approximately 2mm [35]. Gopinath et al. [8] found
that elevated blood pressure was associated with narrower
retinal arterioles in preadolescent boys and girls, and also
with wider retinal venules in boys. In summary, slight
increases in central blood pressure might be involved in
the morphological changes in small retinal arteries, even in
individuals with brachial blood pressure in the normal
range. Therefore, future studies should focus on these Copyright © 2017 Wolters Kluwer
TABLE 5. Association of the central venular equivalent (CRVE) with c
CRVE (odds ratios refer to values
lower than the fifth quantile); All
adjusted for the fellow vessel diameter OR 95% CI P
Sex (reference¼men) 0.984 0.702–1.380 0.9
Age 0.981 0.965–0.998 0.0
Hypertension 0.786 0.549–1.127 0.1
Diabetes 0.649 0.250–1.686 0.3
Smoking 0.555 0.341–0.902 0.0
Dyslipidemia 0.797 0.540–1.178 0.2
Obesity 0.727 0.470–1.125 0.1
Family history of myocardial infarction 0.978 0.638–1.500 0.9
Family history of stroke 1.163 0.655–2.067 0.6
Peripheral arterial occlusive disease 2.257 1.081–4.712 0.0
(medicated) heart failure 1.317 0.356–4.878 0.6
Stroke 1.100 0.299–4.054 0.8
Myocardial infarction 1.711 0.568–5.158 0.3
Fellow vessel (central retinal arteriolar
equivalent) lower than 5th quantile
21.971 15.523–31.096 <0.0
Logistic regression analysis with odds ratios (ORs), 95% confidence intervals (CIs), and P values
CI, confidence interval; OR, odds ratio.
Journal of Hypertensionparameters as indicators for incidence of hypertension
and as markers for compliance and efficacy for antihyper-
tensive therapy.
In GHS, a history of stroke was associated with a lower
AVR in women, and (in the univariate analysis) a higher
CRVE was associated with a family history of stroke. The
association between retinal microvascular characteristics
and (acute ischemic) stroke, dementia, and cerebral
small-vessel disease has been widely investigated: Ong
et al. [51] found an association between narrower arteriolar
calibers and wider venular calibers with stroke. Further-
more, the Cardiovascular Health Study showed an associ-
ation between retinal microvascular signs with poorer
cognitive function and, in persons with hypertension, with
dementia [52]. The follow-up investigation of the GHS will
focus on the relevance of retinal vessel analysis for inci-
dental stroke. Optimally, the normative data of the present Health, Inc. All rights reserved.
ardiovascular risk factors and diseases
Men Women
OR 95% CI P OR 95% CI P
27
25 0.957 0.930–0.984 0.002 0.996 0.975–1.019 0.751
90 0.796 0.462–1.371 0.411 0.802 0.495–1.300 0.371
74 0.464 0.102–2.104 0.319 0.927 0.263–3.264 0.906
18 0.520 0.261–1.037 0.063 0.588 0.294–1.176 0.134
55 0.951 0.558–1.621 0.854 0.617 0.339–1.122 0.113
53 0.497 0.238–1.040 0.064 0.915 0.526–1.592 0.754
19 0.976 0.493–1.930 0.944 0.962 0.552–1.676 0.891
06 1.301 0.537–3.154 0.560 1.040 0.480–2.253 0.921
30 3.358 1.113–10.133 0.032 1.786 0.666–4.788 0.249
80 2.709 0.653–11.253 0.170
86 1.413 0.170–11.745 0.749 0.843 0.151–4.711 0.846
40 3.386 1.001–11.451 0.050
01 21.656 12.288–38.166 <0.001 21.012 13.46–32.792 <0.001
referring to values lower than the fifth percentile.
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TABLE 6. Association of the arteriovenous ratio (AVR) with cardiovascular risk factors and diseases
AVR (odds ratios refer to values All Men Women
lower than the 5fifth percentile) OR 95% CI P OR 95% CI P OR 95% CI P
Sex (reference¼men) 0.772 0.618–0.964 0.022
Age 0.985 0.974–0.996 0.010 0.981 0.965–0.998 0.025 0.988 0.972–1.003 0.120
Hypertension 2.703 2.098–3.848 <0.001 2.414 1.669–3.490 <0.001 3.012 2.126–4.268 <0.001
Diabetes 0.564 0.335–0.948 0.031 0.670 0.346–1.295 0.234 0.428 0.180–1.017 0.055
Smoking 0.843 0.628–1.131 0.255 0.960 0.644–1.430 0.839 0.728 0.469–1.031 0.158
Dyslipidemia 1.073 0.842–1.367 0.568 1.003 0.721–1.396 0.986 1.124 0.783–1.612 0.526
Obesity 1.031 0.798–1.331 0.818 1.000 0.689–1.452 1.000 1.063 0.746–1.516 0.735
Family history of myocardial infarction 0.900 0.673–1.203 0.475 0.801 0.510–1.258 0.335 0.964 0.657–1.415 0.853
Family history of stroke 0.887 0.600–1.312 0.549 0.950 0.522–1.730 0.868 0.846 0.503–1.423 0.528
Peripheral arterial occlusive disease 0.831 0.453–1.526 0.551 1.488 0.690–3.210 0.311 0.422 0.150–1.191 0.103
(medicated) heart failure 0.465 0.142–1.518 0.204 0.779 0.220–2.727 0.698
Stroke 1.308 0.610–2.803 0.491 0.262 0.035–1.955 0.192 2.826 1.151–6.939 0.023
Myocardial infarction 1.326 0.684–2.572 0.403 1.255 0.518–3.041 0.615 1.831 0.648–5.177 0.254
Logistic regression analysis with odds ratios (ORs), 95% confidence intervals (CIs), and P values referring to values lower than the fifth percentile.
CI, confidence interval; OR, odds ratio.
Ponto et al.study will help to identify persons who are at risk for
stroke development.
There are some limitations of the present study: Regard-
ing themethodology itself, there is wide variability in retinal
vessel parameters between individuals, there is a broad
zone of overlap between different groups, and the refer-
ence ranges are relatively large. Therefore, no clear cut-offs
can be suggested for identifying individuals with a higher
risk or insufficiently treated patients. In the randomization,
small but significant differences between the retinal vessel
equivalents in right and left eyes were found. Additionally,
the present normative data are based on specific software.
Furthermore, even though blood pressure was measured
more than once, the at-rest blood pressure measurements
within the study setting might be too high, which could
have biased the classification of hypertension subtypes.
This might have led to an overestimation both of the
‘uncontrolled’ and the ‘screening-detected’ groups. Copyright © 2017 Wolters Kluwe
FIGURE 3 (a, b) Association of stages of systemic hypertension and values for the arter
illustrating medians, quartiles, and ranges. (a) The AVR was lower in participants with un
0.820.07) versus in screening-detected (0.82/0.64–1.05; 0.830.07) and versus in co
test). (b) CRAE was lower in participants with uncontrolled (median/range; mean stand
detected (175.71/ 101.23–222.09; 174.7116.54) and versus in controlled (179.10/ 10
1642 www.jhypertension.comNevertheless, a previous study found that the caliber of
arteriolar retinal vessels in patients with uncontrolled
hypertension was not significantly influenced by blood
pressure measured at the time of retinography acquisition
[53]. Also, the rate of persons with diabetes might have been
underestimated as it was not possible to perform oral
glucose tolerance test within the population-based setting
of the GHS.
Furthermore, it would have improved significance of the
present data if actual diameters instead of vessel equivalents
had been used. Being aware of this limitation, we decided
to use the vessel equivalents instead of the actual diameters
as we aimed to generate normative data not only for the
present study only. Instead, we wanted to make the nomo-
grams also applicable if a correction cannot bemade (if e. g.
refraction data are missing). Additionally, the normative
data from the GHS might not be applicable to individuals
from other populations, especially as ethnic differencesr Health, Inc. All rights reserved.
iovenous ratio (AVR) and the central retinal arteriolar equivalent (CRAE). Box plots
controlled (median/range; mean standard deviation: 0.81/0.56–1.04;
ntrolled (0.84/0.60–1.08; 0.830.07) hypertension (P<0.001, Kruskal–Wallis
ard deviation: 172.28/ 83.05–251.04; 171.8417.49) versus in screening-
8.19–221.92; 177.4616.94) hypertension (P<0.001, Kruskal–Wallis test).
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TABLE 7. Proportion of persons in the three subgroups of hypertension (controlled versus uncontrolled versus screening-detected
hypertension) with values below the reference ranges of the central retinal arteriolar equivalent (CRAE) and the arteriovenous
ratio (AVR)
Sex Age (years) Status of hypertension
Proportion of persons with values
below the reference range, n (%)
AVR P CRAE P
Men 55 No (n¼687) 10 (1.5) <0.001 13 (1.9) 0.0029
Controlled (n¼69) 1 (1.4) 1 (1.4)
Screening-detected (n¼162) 7 (4.3) 3 (1.9)
Uncontrolled (n¼200) 16 (8.0) 13 (6.5)
>55 No (n¼301) 12 (4.0) 0.0233 4 (1.9) 0.5153
Controlled (n¼207) 14 (6.8) 2 (1.9)
Screening-detected (n¼173) 9 (5.2) 2 (1.2)
Uncontrolled (n¼365) 30 (8.2) 3 (0.8)
Women 55 No (n¼799) 21 (2.6) <0.001 25 (3.1) <0.001
Controlled (n¼95) 7 (7.4) 1 (1.1)
Screening-detected (n¼104) 11 (10.6) 9 (8.7)
Uncontrolled (n¼128) 23 (18.0) 21 (16.4)
>55 No (n¼373) 9 (2.4) 0.0078 9 (2.4) 0.0661
Controlled (n¼190) 10 (5.3) 9 (4.7)
Screening-detected (n¼166) 6 (3.6) 5 (3.0)
Uncontrolled (n¼294) 20 (6.8) 15 (5.1)
P values according to the Cochran Armitage test for trend.
Retinal vessel analysis in the GHShave already been reported [54]. Future (extra-European)
studies should test if this holds true across populations as
also other yet unknown or unmeasured environmental
factors or lifestyle habits and genetic variations not related
to ethnicity may also contribute to differences in retinal
vessel parameters [55,56]. Data on retinal vascular tortuosity
are missing, which would have added further information
regarding the effects of cardiovascular risk factors on the
retinal vasculature [46].
Perspectives
Normative data are the basis for the clinical use of quan-
titatively measured parameters. This study, for the first
time, provides nomograms and reference ranges for retinal
vesselmetrics. In theGHS, these datawere different among
patients with unknown (screening-detected), uncon-
trolled, and controlled hypertension. As the GHS is a
longitudinal study, participants are completely assessed
every 5 years. Therefore, we will be able to analyze the
relevance of the normative data for the whole GHS cohort,
for different disease groups, and also for the subgroup of
‘healthy’ individuals in future studies. We will assess the
changes of the vessel equivalents during the follow-up,
and furthermore address, for example, the following ques-
tions: Is there an association between normal/high/low
retinal vessel equivalents and cardiovascular events during
follow-up? Did the vessel equivalents improve in patients
who were sufficiently treated, for example, their hyper-
tension during this time? If we find that the nomograms are
helpful to forecast cardiovascular events and to longitudi-
nally objectify efficacy and compliance to (e.g. antihyper-
tensive) therapies, we will further discuss their use to
contribute to existing diagnostic tools and reference
values. Potentially, retinal vessel parameters might be,
together with other clinical parameters, a useful tool for
monitoring compliance and efficacy of antihypertensive
therapy. Copyright © 2017 Wolters Kluwer
Journal of HypertensionVarious semiautomated, computer-based programs have
been used to assess in-vivo architectural changes in the
retinal vascular network [3]. The software used in this study
is not costly; it only requires a standard fundus camera,
and handling can be learned easily. This was attested by
the good interobserver variability found in the present
study. Present and future data from the GHS and from
joint projects within the European Eye Epidemiology
(E3) Consortium [22] will hopefully contribute to the trans-
lation of retinal vessel analysis into a tool for improving the
diagnosis, prognosis, and management of hypertension in
clinical practice and photographing the retina for analysis
will become routine.
ACKNOWLEDGEMENTS
We thank all study participants for their willingness to
provide data for this research project, and we are indebted
to all co-workers for their enthusiastic commitment.
Sources of funding: The Gutenberg Health Study is
funded through the government of Rhineland-Palatinate
(’Stiftung Rheinland-Pfalz fu¨r Innovation,’ contract AZ 961–
386261/733), the research programs ‘Wissen schafft
Zukunft’ and ‘Center for Translational Vascular Biology
(CTVB),’ and also the Center for Thrombosis and Hemo-
stasis (CTH) of the Johannes Gutenberg University of
Mainz, and its contract with Boehringer Ingelheim, PHILIPS
Medical Systems, and Novartis, including an unrestricted
grant for the Gutenberg Health Study.
Conflicts of interest
P.S.W. and K.A.P. are funded by the Federal Ministry of
Education and Research (BMBF 01EO1003). P.S.W. is prin-
cipal investigator of the German Center for Cardiovascular
Research (DZHK). The funders had no role in the study
design, data analysis, decision to publish, or preparation of
the manuscript. Health, Inc. All rights reserved.
www.jhypertension.com 1643
Ponto et al.REFERENCES
1. Ikram MK, Ong YT, Cheung CY, Wong TY. Retinal vascular caliber
measurements: clinical significance, current knowledge and future
perspectives. Int J Ophthalmol 2013; 229:125–136.
2. Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal micro-
vasculature as a model to study the manifestations of hypertension.
Hypertension 2012; 60:1094–1103.
3. Sun C, Wang JJ, Mackey DA, Wong TY. Retinal vascular caliber:
systemic, environmental, and genetic associations. Survey Ophthalmol
2009; 54:74–95.
4. Wong TY, Islam FM, Klein R, Klein BE, CotchMF, Castro C, et al. Retinal
vascular caliber, cardiovascular risk factors, and inflammation: the
multiethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis
Sci 2006; 47:2341–2350.
5. DellaCroce JT, Vitale AT. Hypertension and the eye. Curr Opin
Ophthalmol 2008; 19:493–498.
6. Schuster AK, Fischer JE, Vossmerbaeumer U. A retinal snap shot may
indicate individual risk for cardiovascular disease: the MIPH Eye and
Health Study. Int J Cardiol 2015; 180:30–33.
7. Mutlu U, Ikram MK, Wolters FJ, Hofman A, Klaver CC, Ikram MA.
Retinal microvasculature is associated with long-term survival in the
general adult Dutch population. Hypertension 2016; 67:281–287.
8. Gopinath B, Baur LA, Wang JJ, Teber E, Liew G, Cheung N, et al. Blood
pressure is associated with retinal vessel signs in preadolescent chil-
dren. J Hypertens 2010; 28:1406–1412.
9. CheungN, BluemkeDA, Klein R, Sharrett AR, Islam FM, CotchMF, et al.
Retinal arteriolar narrowing and left ventricular remodeling: the multi-
ethnic study of atherosclerosis. J Am Coll Cardiol 2007; 50:48–55.
10. Garcia-Ortiz L, Recio-Rodriguez JI, Parra-Sanchez J, Gonzalez Elena LJ,
Patino-Alonso MC, Agudo-Conde C, et al. A new tool to assess retinal
vessel caliber. Reliability and validity of measures and their relationship
with cardiovascular risk. J Hypertens 2012; 30:770–777.
11. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal
vascular image analysis as a potential screening tool for cerebro-
vascular disease: a rationale based on homology between cerebral
and retinal microvasculatures. J Anatomy 2005; 206:319–348.
12. Sabanayagam C, Tai ES, Shankar A, Lee J, Sun C, Wong TY. Retinal
arteriolar narrowing increases the likelihood of chronic kidney disease
in hypertension. J Hypertens 2009; 27:2209–2217.
13. Lupton SJ, Chiu CL, Hodgson LA, Tooher J, Ogle R, Wong TY, et al.
Changes in retinal microvascular caliber precede the clinical onset of
preeclampsia. Hypertension 2013; 62:899–904.
14. Li LJ, Cheung CY, Ikram MK, Gluckman P, Meaney MJ, Chong YS, et al.
Blood pressure and retinal microvascular characteristics during preg-
nancy: Growing Up in Singapore Towards Healthy Outcomes
(GUSTO) Study. Hypertension 2012; 60:223–230.
15. Sun C, Liew G, Wang JJ, Mitchell P, Saw SM, Aung T, et al. Retinal
vascular caliber, blood pressure, and cardiovascular risk factors in an
Asian population: the Singapore Malay Eye Study. Invest Ophthalmol
Vis Sci 2008; 49:1784–1790.
16. Wang L, Wong TY, Sharrett AR, Klein R, Folsom AR, Jerosch-Herold M.
Relationship between retinal arteriolar narrowing and myocardial
perfusion: multiethnic study of atherosclerosis. Hypertension 2008;
51:119–126.
17. Cheung N, Sharrett AR, Klein R, Criqui MH, Islam FM, Macura KJ, et al.
Aortic distensibility and retinal arteriolar narrowing: the multiethnic
study of atherosclerosis. Hypertension 2007; 50:617–622.
18. de Jong FJ, Schrijvers EM, IkramMK, Koudstaal PJ, de Jong PT, Hofman
A, et al. Retinal vascular caliber and risk of dementia: the Rotterdam
study. Neurology 2011; 76:816–821.
19. Mutlu U, Adams HH, Hofman A, Lugt A, Klaver CC, Vernooij MW, et al.
Retinal microvascular calibers are associated with enlarged perivas-
cular spaces in the brain. Stroke 2016; 47:1374–1376.
20. Mutlu U, Cremers LG, de Groot M, Hofman A, NiessenWJ, van der Lugt
A, et al. Retinal microvasculature and white matter microstructure: the
Rotterdam study. Neurology 2016; 6:1003–1010.
21. Ding J, Wai KL, McGeechan K, Ikram MK, Kawasaki R, Xie J, et al.
Retinal vascular caliber and the development of hypertension: a meta-
analysis of individual participant data. J Hypertens 2014; 32:207–215.
22. Delcourt C, Korobelnik JF, Buitendijk GH, Foster PJ, Hammond CJ,
Piermarocchi S, et al. Ophthalmic epidemiology in Europe: the ‘Euro-
pean Eye Epidemiology’ (E3) consortium. Eur J Epidemiol 2016;
31:197–210. Copyright © 2017 Wolters Kluwe
1644 www.jhypertension.com23. Williams KM, Verhoeven VJ, Cumberland P, Bertelsen G, Wolfram C,
Buitendijk GH, et al. Prevalence of refractive error in Europe: the
European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol 2015;
30:305–315.
24. Hohn R, Kottler U, Peto T, Blettner M, Munzel T, Blankenberg S, et al.
The ophthalmic branch of the Gutenberg Health Study: study design,
cohort profile and self-reported diseases. PloS One 2015; 10:e0120476.
25. Michal M, Wiltink J, Lackner K, Wild PS, Zwiener I, Blettner M,
et al. Association of hypertension with depression in the community:
results from the Gutenberg Health Study. J Hypertens 2013; 31:893–
899.
26. Neuhauser H, Diederichs C, Boeing H, Felix SB, Junger C, Lorbeer R,
et al. Hypertension in Germany. Deutsches Arzteblatt Int 2016;
113:809–815.
27. Ponto KA, Elbaz H, Peto T, Laubert-Reh D, Binder H, Wild PS, et al.
Prevalence and risk factors of retinal vein occlusion: the Gutenberg
Health Study. J Thromb Haemost 2015; 13:1254–1263.
28. Raum P, Lamparter J, Ponto KA, Peto T, Hoehn R, Schulz A, et al.
Prevalence and cardiovascular associations of diabetic retinopathy and
maculopathy: results from the Gutenberg Health Study. PloS One 2015;
10:e0127188.
29. Lamparter J, Raum P, Pfeiffer N, Peto T, Hohn R, Elflein H, et al.
Prevalence and associations of diabetic retinopathy in a large cohort of
prediabetic subjects: the Gutenberg Health Study. J Diabetes Compli-
cations 2014; 28:482–487.
30. Hubbard LD, Brothers RJ, KingWN, Clegg LX, Klein R, Cooper LS, et al.
Methods for evaluation of retinal microvascular abnormalities associ-
ated with hypertension/sclerosis in the Atherosclerosis Risk in Com-
munities Study. Ophthalmology 1999; 106:2269–2280.
31. Parr JC, Spears GF. Mathematic relationships between the width of a
retinal artery and the widths of its branches. Am J Ophthalmol 1974;
77:478–483.
32. R Core Team. R: A Language and environment for statistical comput-
ing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
33. Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging: a new
tool in microvascular disease research. Circ Cardiovasc Imaging 2008;
1:156–161.
34. Ikram MK, Witteman JC, Vingerling JR, Breteler MM, Hofman A, de
Jong PT. Retinal vessel diameters and risk of hypertension: the
Rotterdam study. Hypertension 2006; 47:189–194.
35. Mitchell P, Cheung N, de Haseth K, Taylor B, Rochtchina E, Islam FM,
et al. Blood pressure and retinal arteriolar narrowing in children.
Hypertension 2007; 49:1156–1162.
36. Leung H, Wang JJ, Rochtchina E, Tan AG, Wong TY, Klein R, et al.
Relationships between age, blood pressure, and retinal vessel
diameters in an older population. Invest Ophthalmol Vis Sci 2003;
44:2900–2904.
37. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel
diameters and their associations with age and blood pressure. Invest
Ophthalmol Vis Sci 2003; 44:4644–4650.
38. Kawasaki R, Wang JJ, Rochtchina E, Taylor B, Wong TY, Tominaga M,
et al. Cardiovascular risk factors and retinal microvascular signs in an
adult Japanese population: the Funagata Study. Ophthalmology 2006;
113:1378–1384.
39. Wong TY, Klein R, Sharrett AR, Manolio TA, Hubbard LD, Marino EK,
et al. The prevalence and risk factors of retinal microvascular abnor-
malities in older persons: The Cardiovascular Health Study. Ophthal-
mology 2003; 110:658–666.
40. Sorensen BM,Houben AJ, Berendschot TT, Schouten JS, Kroon AA, van
der Kallen CJ, et al. Prediabetes and type 2 diabetes are associated with
generalized microvascular dysfunction: the Maastricht study. Circula-
tion 2016; 134:1339–1352.
41. Hanssen H, Nickel T, Drexel V, Hertel G, Emslander I, Sisic Z, et al.
Exercise-induced alterations of retinal vessel diameters and cardio-
vascular risk reduction in obesity. Atherosclerosis 2011; 216:433–
439.
42. Hanssen H, Siegrist M, Neidig M, Renner A, Birzele P, Siclovan A, et al.
Retinal vessel diameter, obesity and metabolic risk factors in school
children (JuvenTUM 3). Atherosclerosis 2012; 221:242–248.
43. Joris PJ, Plat J, Kusters YH, Houben AJ, Stehouwer CD, Schalkwijk CG,
et al. Diet-induced weight loss improves not only cardiometabolic
risk markers but also markers of vascular function: a randomized
controlled trial in abdominally obese men. Am J Clin Nutr 2017;
105:23–31.r Health, Inc. All rights reserved.
Volume 35  Number 8  August 2017
Retinal vessel analysis in the GHS44. Aissopou EK, Argyris AA, Nasothimiou EG, Konstantonis GD,
Tampakis K, Tentolouris N, et al. Ambulatory aortic stiffness is associ-
ated with narrow retinal arteriolar caliber in hypertensives: the SAFAR
study. Am J Hypertens 2016; 29:626–633.
45. McGowan A, Silvestri G, Moore E, Silvestri V, Patterson CC, Maxwell
AP, et al. Evaluation of the retinal vasculature in hypertension and
chronic kidney disease in an elderly population of Irish nuns. PloS One
2015; 10:e0136434.
46. Cheung CY, Zheng Y, Hsu W, Lee ML, Lau QP, Mitchell P, et al. Retinal
vascular tortuosity, blood pressure, and cardiovascular risk factors.
Ophthalmology 2011; 118:812–818.
47. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE, et al.
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med
2004; 140:248–255.
48. Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective
cohort study of retinal vessel diameters and risk of hypertension. BMJ
(Clinical Research ed) 2004; 329:79.
49. Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR, et al.
Retinal arteriolar narrowing is associated with 5-year incident severe
hypertension: the Blue Mountains Eye Study. Hypertension 2004;
44:442–447.
50. Kumagai K, Tabara Y, Yamashiro K, Miyake M, Akagi-Kurashige Y,
Oishi M, et al. Central blood pressure relates more strongly to retinal Copyright © 2017 Wolters Kluwer
Journal of Hypertensionarteriolar narrowing than brachial blood pressure: the Nagahama
Study. J Hypertens 2015; 33:323–329.
51. Ong YT, De Silva DA, Cheung CY, Chang HM, Chen CP, Wong MC,
et al.Microvascular structure and network in the retina of patients with
ischemic stroke. Stroke 2013; 44:2121–2127.
52. BakerML, Marino Larsen EK, Kuller LH, Klein R, Klein BE, Siscovick DS,
et al. Retinal microvascular signs, cognitive function, and dementia in
older persons: the Cardiovascular Health Study. Stroke 2007; 38:2041–
2047.
53. Fuchs SC, Pakter HM, Maestri MK, Beltrami-Moreira M, Gus M, Moreira
LB, et al. Are retinal vessels calibers influenced by blood pressure
measured at the time of retinography acquisition? PloS One 2015;
10:e0136678.
54. Cheung N, Islam FM, Saw SM, Shankar A, de Haseth K, Mitchell P, et al.
Distribution and associations of retinal vascular caliber with ethnicity,
gender, and birth parameters in young children. Invest Ophthalmol Vis
Sci 2007; 48:1018–1024.
55. Sun C, Ponsonby AL, Wong TY, Brown SA, Kearns LS, Cochrane J, et al.
Effect of birth parameters on retinal vascular caliber: the Twins Eye
Study in Tasmania. Hypertension 2009; 53:487–493.
56. Li X, Wong WL, Cheung CY, Cheng CY, Ikram MK, Li J, et al. Racial
differences in retinal vessel geometric characteristics: a multiethnic
study in healthy Asians. Invest Ophthalmol Vis Sci 2013; 54:3650–3656.Reviewers’ Summary Evaluations
Referee 1
The study is impressive in the large number of subjects
tested, the rigorous classification of subjects in terms of BP
status and CV status. The retinal vessel assessments were
standardized based on retinal photographs and use of a
propriety software tool. The findings relating vessel
diameters to HTN and CV risk factors as well as older
age and male gender are confirmatory of multiple other
studies, but the normative values for healthy adults does
seemingly provide an important reference that has been
lacking. The study is limited in having assessed a very
homogenous cohort and so extrapolation to more diverse
populations may not be valid.Referee 2
In this population-based study fundus photographs from
4309 participants were analyzed. A subset of 890 cardio-
vascular healthy individuals was used to generate age and
sex-specific nomograms for retinal vessel diameters. These
reference ranges may contribute to improvement of hyper-
tension management in clinical practice and add useful
information to cardiovascular risk stratification in these
patients. Possible limitations are the large interindividual
variability in retinal vascular diameters resulting in large
reference ranges and overlap in diameter ranges between
patient groups, and diameters are presented as vessel
equivalents instead of actual diameters. Health, Inc. All rights reserved.
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